BiotechTube

Azithromycin plus hydroxychloroquine

Phase 3Withdrawn
0 views this week 0 watching💤 Quiet
Interest: 22/100
22
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Respiratory Tract Infection Viral

Conditions

Respiratory Tract Infection Viral

Trial Timeline

Feb 8, 2021 → Aug 26, 2021

NCT ID
NCT05026801

About Azithromycin plus hydroxychloroquine

Azithromycin plus hydroxychloroquine is a phase 3 stage product being developed by Iterum Therapeutics for Respiratory Tract Infection Viral. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT05026801. Target conditions include Respiratory Tract Infection Viral.

What happened to similar drugs?

10 of 20 similar drugs in Respiratory Tract Infection Viral were approved

Approved (10) Terminated (3) Active (9)
✅Zopapogene imadenovec (Zopa)PrecigenApproved
✅YMC026 + PlaceboYuhanApproved
✅Montelukast + PlaceboMerckApproved
✅Sugammadex 100 MG/ML [Bridion]MerckApproved
✅diclofenac potassium + nimesulideNovartisApproved
✅Bacterial Lysates + placeboSanofiApproved
✅Telithromycin + AzithromycinSanofiApproved

Hype Score Breakdown

Clinical
17
Activity
0
Company
5
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT05026801Phase 3Withdrawn

Competing Products

20 competing products in Respiratory Tract Infection Viral

See all competitors
ProductCompanyStageHype Score
mRNA-1273ModernaPhase 1
0
mRNA-1345ModernaPhase 3
0
mRNA-1345ModernaPhase 1
0
mRNA-1345ModernaPhase 2
0
mRNA-1345ModernaPhase 2
0
mRNA-1345ModernaPhase 3
0
mRNA-1345ModernaPhase 3
0
mRNA-1345ModernaPreclinical
0
mRNA-1345ModernaPhase 3
0
mRNA-1345ModernaPhase 3
0
mRNA-1345ModernaPhase 1
0
Zopapogene imadenovec (Zopa)PrecigenApproved
44
PRGN-2012 - Phase I; Dose Level 1 + PRGN-2012 - Phase I; Dose Level 2 + PRGN-2012 - Phase II; Dose Level 2PrecigenPhase 1/2
30
agenT-797MiNK TherapeuticsPhase 1
19
YMC026 + PlaceboYuhanApproved
43
VN-0200 + PlaceboDaiichi SankyoPhase 1
29
VN-0200Daiichi SankyoPhase 2
35
Isavuconazonium Injection [Cresemba] + PlaceboAstellas PharmaPhase 3
32
S-337395 + PlaceboShionogiPhase 2
42
SivelestatEli LillyPhase 1/2
32